Tsutomu Ogata

Tsutomu Ogata

Auto-generated profile, based on publicly available information

Tsutomu Ogata

Department of Biochemistry, Hamamatsu University School of Medicine , Hamamatsu 431-3192

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2014 in BMC Public Health
Verified
Journal Article
Open access
PDF file
WHWorking Group of the Epidemiological Research for Children’s Environmental Health
Working Group of the Epidemiological Research for Children’s Environmental Health
TKToshihiro Kawamoto
Toshihiro Kawamoto
HNHiroshi Nitta
Hiroshi Nitta
KMKatsuyuki Murata
Katsuyuki Murata
ETEisaku Toda
Eisaku Toda
HSHiroshi Satoh
Hiroshi Satoh
There is global concern over significant threats from a wide variety of environmental hazards to which children face. Large-scale and long-term birth cohort studies are needed for better environmental management based on sound science. The primary objective of the Japan Environment and Children’s Study (JECS), a nation-wide birth cohort study that started its recruitment in January 2011, is to elucidate environmental factors that affect children’s health and development.

1 May 1997 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
ERErcole Rao
Ercole Rao
BWBirgit Weiss
Birgit Weiss
MFMaki Fukami
Maki Fukami
ARAndreas Rump
Andreas Rump
BNBeate Niesler
Beate Niesler
GRGudrun A. Rappold
Gudrun A. Rappold

15 October 2002 in Nature Genetics
Verified
Journal Article
Closed access
KKKunio Kitamura
Kunio Kitamura
MYMasako Yanazawa
Masako Yanazawa
NSNoriyuki Sugiyama
Noriyuki Sugiyama
HMHirohito Miura
Hirohito Miura
AIAkiko Iizuka-Kogo
Akiko Iizuka-Kogo
KMKen-Ichirou Morohashi
Ken-Ichirou Morohashi

2 September 2016 in Nature Reviews Endocrinology
Verified
Journal Article
Open access
PDF file
EWEmma L. Wakeling
Emma L. Wakeling
FBFrédéric Brioude
Frédéric Brioude
OLOluwakemi Lokulo-Sodipe
Oluwakemi Lokulo-Sodipe
SOSusan M. O'Connell
Susan M. O'Connell
JSJennifer Salem
Jennifer Salem
INIrène NETCHINE
Irène NETCHINE
This Consensus Statement summarizes recommendations for clinical diagnosis, investigation and management of patients with Silver–Russell syndrome (SRS), an imprinting disorder that causes prenatal and postnatal growth retardation. Considerable overlap exists between the care of individuals born small for gestational age and those with SRS. However, many specific management issues exist and evidence from controlled trials remains limited. SRS is primarily a clinical diagnosis; however, molecular testing enables confirmation of the clinical diagnosis and defines the subtype. A 'normal' result from a molecular test does not exclude the diagnosis of SRS. The management of children with SRS requires an experienced, multidisciplinary approach. Specific issues include growth failure, severe feeding difficulties, gastrointestinal problems, hypoglycaemia, body asymmetry, scoliosis, motor and speech delay and psychosocial challenges. An early emphasis on adequate nutritional status is important, with awareness that rapid postnatal weight gain might lead to subsequent increased risk of metabolic disorders. The benefits of treating patients with SRS with growth hormone include improved body composition, motor development and appetite, reduced risk of hypoglycaemia and increased height. Clinicians should be aware of possible premature adrenarche, fairly early and rapid central puberty and insulin resistance. Treatment with gonadotropin-releasing hormone analogues can delay progression of central puberty and preserve adult height potential. Long-term follow up is essential to determine the natural history and optimal management in adulthood.

1 June 2008 in Trends in Genetics
Verified
Journal Article
Closed access
SRSimão Teixeira Rocha
Simão Teixeira Rocha
CECarol A. Edwards
Carol A. Edwards
MIMitsuteru Ito
Mitsuteru Ito
TOTsutomu Ogata
Tsutomu Ogata
AFAnne Ferguson-Smith
Anne Ferguson-Smith

8 January 2014 in Genome Research
Verified
Journal Article
Open access
PDF file
FCFranck Court*
Franck Court*
CTChiharu Tayama
Chiharu Tayama
VRValeria Romanelli
Valeria Romanelli
AMAlex Martin-Trujillo
Alex Martin-Trujillo
IIIsabel Iglesias-Platas
Isabel Iglesias-Platas
DMDavid Monk
David Monk
Differential methylation between the two alleles of a gene has been observed in imprinted regions, where the methylation of one allele occurs on a parent-of-origin basis, the inactive X-chromosome in females, and at those loci whose methylation is driven by genetic variants. We have extensively characterized imprinted methylation in a substantial range of normal human tissues, reciprocal genome-wide uniparental disomies, and hydatidiform moles, using a combination of whole-genome bisulfite sequencing and high-density methylation microarrays. This approach allowed us to define methylation profiles at known imprinted domains at base-pair resolution, as well as to identify 21 novel loci harboring parent-of-origin methylation, 15 of which are restricted to the placenta. We observe that the extent of imprinted differentially methylated regions (DMRs) is extremely similar between tissues, with the exception of the placenta. This extra-embryonic tissue often adopts a different methylation profile compared to somatic tissues. Further, we profiled all imprinted DMRs in sperm and embryonic stem cells derived from parthenogenetically activated oocytes, individual blastomeres, and blastocysts, in order to identify primary DMRs and reveal the extent of reprogramming during preimplantation development. Intriguingly, we find that in contrast to ubiquitous imprints, the majority of placenta-specific imprinted DMRs are unmethylated in sperm and all human embryonic stem cells. Therefore, placental-specific imprinting provides evidence for an inheritable epigenetic state that is independent of DNA methylation and the existence of a novel imprinting mechanism at these loci.